G6PD and malaria: This is particularly relevant for the test’s use in malaria case management, as standard 14-day primaquine regimens used for the radical cure of P. vivax malaria are not recommended for G6PD deficient males and females, [38,39] and safety of higher dose regimens among G6PD intermediate females is also a concern [40].